One such recent study showed that the anti-TNF antibody adalimumab promoted the interaction between monocytes and Tregs from RA patients by binding to monocyte membrane bound TNF, enhancing its expression and its binding to TNF-RII expressed on Tregs [57]. The gene discussed is TNFRSF1B; the disease is rheumatoid arthritis.